Targeting IGF2BP3 enhances antileukemic effects of menin-MLL inhibition in MLL-AF4 leukemia.

Blood Adv · 2024 · PMC10824693 · PMID 38048400

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantP = 0not a probability at all

Remarkably, there is a highly significant overlap between genes that are differentially expressed with IGF2BP3 knockdown and MI-503 treatment (Hypergeometric test; P = 0).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.